Comparative effects of pre-gestational doses of clomiphene citrate versus letrozole on the heart of developing wistar rats by Olulana, Dare Isaac & Popoola, Covenant





Submitted 16th October 2019. Published online 5th December 2019. To cite: Olulana DI, Covenant Popoola C. 2021. 
Comparative effects of pre-gestational doses of Clomiphene Citrate versus Letrozole on the heart of developing Wistar rats 
 Anatomy Journal of Africa. 10 (1): 1871 - 1877. 
 
COMPARATIVE EFFECTS OF PRE-GESTATIONAL DOSES OF 
CLOMIPHENE CITRATE VERSUS LETROZOLE ON THE HEART OF 
DEVELOPING WISTAR RATS 
Dare Isaac Olulana1,2, Covenant Popoola2                                
1. Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria 
2. Department of Anatomy, College of Medicine, University of Ibadan, Ibadan, Nigeria 
Correspondence to Dr Dare I. Olulana Department of Surgery, College of Medicine, University of Ibadan, 
Ibadan, Nigeria. Email:- isaacdare@yahoo.com. Phone:- +234-802-1196-701 
 
ABSTRACT 
Drug-induced ovulation is a therapy that allows women to ovulate and have the chance of conceiving. 
This therapy is used either in women with irregular ovulation or in patients undergoing In-vitro 
fertilization cycle to maximize egg production. The goal of drug-induced ovulation is to stimulate the 
ovaries to produce a single mature follicle and allow fertilization and pregnancy to occur. The drugs 
commonly used are clomiphene citrate and letrozole. There are indications that these drugs, when used 
prenatally, could interfere with the normal development of foetal hearts, though; there is a paucity of 
data on the lethal effects of drug-induced ovulation on the neonatal heart, particularly the left ventricle 
and ventricular septum. Forty-five adult female Wistar rats that weighed between 140-160g were used 
for the experiment. They were subdivided into three groups of 15 animals each. A vaginal smear was 
carried out to further divide the experimental animals based on their oestrous phases. A one-time dose 
of clomiphene citrate (clomid) was administered at 0.5mg/kg bodyweight, to one of the experimental 
groups, during the diestrous phase. The other experimental group received Letrozole at 0.025mg/kg 
bodyweight while the control group received normal feed and water liberally. Mating was done a day 
after administration of these drugs. Pups were sacrificed on postnatal day 21, the hearts of the pups 
were dissected out and processed for histological analysis. The result showed that the pups whose 
mothers received clomid had the lowest heart weights compared to the letrozole and control groups.  
The left ventricular wall thickness was greater in the Letrozole group and the level of necrosis was 
observed to be greater in the clomid group as compared to the other groups. These findings show that 
both clomid and letrozole have some effects on the hearts of the developing wistar rats. 
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INTRODUCTION 
Infertility is failure to achieve pregnancy by a 
couple despite regular unprotected sexual 
intercourse over a period of one year or the 
inability to carry pregnancy to term (Olooto, et 
al., 2012). Drug-induced ovulation has proved to 
be one of the ways to manage anovulatory 
infertility and also to maximize egg production in 
women undergoing Assisted Reproductive 
Technology (ART) cycles (Katsikis et al., 2006). 
Indications for the use of ovulation induction 
therapies include infrequent ovulation, 
anovulation, unexplained infertility despite 
regular ovulation, as well as in women 
undergoing In-vitro fertilization to maximize egg 
production (Wayne State University Physician 
Group, 2014). 
The commonest drug used for induction of 
ovulation is Clomiphene citrate. It can be very 
effective, cheap and user-friendly. The dosage is 
50-250 mg per day for 5 days to be commenced 
2, 3, 4, or 5 days after spontaneous or induced 
menstrual bleeding. Starting with the lowest, the 




dose can be raised in increments of 50 mg per 
day per cycle until an ovulatory cycle is achieved. 
Though efficient in achieving ovulation, use of 
clomiphene is a risk factor for congenital 
anomalies (Sovino et al., 2002). High serum 
levels of luteinizing hormone (LH) and especially 
the anti-oestrogenic effects of clomiphene on the 
endometrium and cervical mucus may make 
clomiphene citrate to interfere with fertility 
(Casper and Mitwally, 2006, Pavone and Bulun, 
2013). The drug is rapidly absorbed in the 
intestine and remains in the body for about 5 
days while the drug and its metabolite can be 
picked in the stool about 6 weeks after its 
administration. (Imani et al., 2002). This is a 
probable explanation for its interference with 
cardiac development in utero. 
Letrozole is cheap, has short half-life and 
insignificant side effects. Its use has been 
studied in women with polycystic ovary 
syndrome (PCOS), women who are resistant to 
clomiphene citrate, in intrauterine insemination 
and also in various protocols of mild stimulation 
for in vitro fertilization/intracytoplasmic sperm 
injection (IVF/ICSI). However, the efficacy and 
safety of the drug is not certain (Kar, 2013). At 
doses of 1–5 mg, letrozole inhibits estrogen 
levels by at least 97–99% (Polyzos et al., 2011). 
In premenopausal women, letrozole stimulates 
the development of the follicles necessitating the 
use of aromatase inhibitors for ovulation 
induction. It does this by decreasing the serum 
levels of oestrogen which in turn stimulates the 
production of FSH by the pituitary gland. The 
resulting increase in FSH levels will stimulate the 
development of the follicles (Ferrero et al., 
2009). Investigation of a causal association 
between a drug therapy and congenital cardiac 
malformation must include knowledge of the 
timeline of normal cardiac development which 
begins in the third week of foetal development 
in humans. 
Congenital anomalies are structural or functional 
defects that arise prenatally and may be 
identified during pregnancy, at birth, or later in 
infancy (WHO, 2016). They can have a serious, 
adverse effect on the health, development, or 
functional ability of the baby. The evidences that 
pregnancies following treatments by anti-
estrogens (clomiphene citrate) and aromatase 
inhibitors (letrozole) have the potential of 
resulting into certain congenital anomalies have 
been inconclusive (Biljan et al., 2005; Sharma et 
al., 2014). 
 
MATERIALS AND METHOD 
Forty-five adult female Wistar rats weighing 140-
160g were procured from the Central Animal 
House, University of Ibadan, Ibadan, Nigeria. 
The animals were acclimatized in well ventilated 
cages for 2 weeks with liberal access to feed and 
water. Vaginal smear cytology was done to 
determine their different phases of estrous cycle. 
They were randomly subdivided into three 
groups of fifteen animals each. 
Group 1: Rats on normal feed and water 
Group 2: Rats given 0.5mg of clomiphene citrate 
per kilogram bodyweight 
Group 3: Rats given 0.025mg of letrozole per 
kilogram bodyweight 
The required doses of clomiphene and letrozole 
were given to the rats according to the body 
weight of the rats using an oral cannula. Rats 
received a one-time administration during the 
diestrous phase specifically, because, this is the 
phase characterized by the development of 
primordial follicle. Clomiphene citrate tablets 
50mg (Clomid – Sanofi Aventis, France) was 
purchased from the Pharmacy store and 
preserved appropriately. About 50mg of Clomid 
was dissolved in 50mls of distilled water to have 
1mg of clomiphene citrate 1ml of water. 
Therefore, with an average weight of 150g, rats 
received a one-time single dose of 0.075mls with 
the use of an oral cannula. Letrozole tablets 
2.5mg (Femara – Novartis, India) was also 
purchased from the Pharmacy store and 




preserved appropriately. About 2.5mg of 
Letrozole was also dissolved in 50mls of water to 
have 0.05mg of Letrozole in 1ml of water. 
Therefore, with an average weight of 150g, rats 
received a one-time single dose of 0.075mls with 
the use of an oral cannula. 
A day after administration of these drugs (pro-
estrous phase), male rats were introduced prior 
to the oestrous phase to give an opportunity for 
fertilization during estrous phase. The rats were 
examined daily for vaginal plug and 
microscopically for sperm cells to confirm 
pregnancy. The resulting pups from these 
pregnancies were sacrificed 21 days after 
delivery. The hearts of the pup were dissected 
out, weighed and processed for histology using 
haematoxyline and eosin staining technique. 
The average number of litters was noted and left 
ventricular wall thickness was also measured. 
The resulting values were expressed as Mean ± 
Standard deviation (SD). One-way analysis of 
variance (ANOVA) was used to compare the 
quantitative histological parameters among the 
groups. Post hoc Tukey’s test was applied to 
show which groups’ mean differs; p-values were 
calculated with 0.05 taken as being significant. 
 
RESULTS 
The average number of litters in Group 1 was 
(6.2±1.30), Group 2 (7.0±2.83) and (6.8±1.09) 
are comparably similar across the groups 
although, the average number of litters is slightly 
more in Group 2 (clomiphene citrate) than in 
Group 3 (Letrozole). The mean weight of the 
hearts of the pups was significantly lowest in 
Group 2 (0.205±0.004g) and highest in Group 1 
(0.413±0.06g) animals (Table 1).  
The average thickness of the wall of the left 
ventricles of the pups was significantly highest in 
Group 1 (207.2±110.9mm) and lowest in Group 
2 (86.24±39.06mm). There was no hypertrophy 
of the left ventricular wall across the group but 
there were evidences of muscular degeneration 
among the experimental groups (Table 2). 
The microscopic examination of cardiac tissues 
of the left ventricles of the pups using H&E stains 
revealed that the cardiac tissue obtained from 
the day 21 pups of the control group were of 
normal myocardial histology (Fig. 1). 
Table 1: Mean heart weights (in grammes) 
  Groups                                                                       Weights(g) 
1 - Control                                                                0.413 ± 0.06 
11 - Clomiphene Citrate                                                  0.205 ± 0.004 
111 - Letrozol                                                                0.237 ± 0.01 
 
Table 2: Average left ventricular wall thickness (in millimeters) 
Group                                          Left ventricular wall thickness (mm) 
I – Control                                                             86.24 ± 39.06  
11 – Clomiphene Citrate                                         90.22 ± 55.38 
111 – Letrozol                                                          207.2 ± 110.9 
 




   





                              A                                                                 B 
There were clear transverse striations and 
abundant cardiomyocytes in the myocardium. 
There was no inflammatory cell infiltration. 
About 70% of the cardiac tissues harvested from 
the clomiphene citrate group showed severe 
necrosis in the myocardial layer resulting in 
obvious separation of cardiac myofibrils. Also 
observed in this layer, was infiltration of 
inflammatory cells among necrotic cardiac 
myocytes. This occurrence was quite severe in 
the clomiphene citrate group.  About 20% of the 
cardiac tissues obtained from the letrozole group 
showed mild necrosis and few inflammatory cells 
in the myocardium (Fig. 2). Apparently, the 
experimental groups presented with some level 
of myocardial infarction. 
 
 
Figure 1: Photomicrographs of the left ventricle of a heart section from the control (A), clomiphene citrate (B), 
letrozole (C) groups stained with Haematoxylin and Eosin X400. Figure A shows normal heart tissue with normal 
myocardial layer (black arrow). Figure B shows severe necrosis (black arrow) in the myocardial layer. Figure C 
shows mild necrosis in the myocardial layer (black arrow). 
Figure 2: Photomicrograph of the left ventricle of a heart section from the clomiphene citrate (A) and letrozole 
(B) groups stained by Haematoxylin and Eosin X400. Figure A shows focal area of infiltration of inflammatory cells 
(slender arrow), figure B shows few inflammatory cells and mild necrosis within the myocardium (thick arrow). 





The incidence of multiple pregnancies is more 
common with the use of clomiphene citrate than 
letrozole (Sovino et al., 2002, Reefhuis et al., 
2011). More workers have reported above 
findings that letrozole use can be associated with 
a significantly lower multiple gestation rates than 
the use of clomiphene citrate (Mitwally et al., 
2005). This is also our observation in this study 
in which higher number of litters were born to 
the mothers who received clomiphene citrate 
compared to those in the letrozole group. Low 
birth weight might not necessarily amount to low 
heart weights and low heart weight has not been 
previously reported in humans or animals who 
received clomiphene citrate. However, in 1993, 
Dziadek, who carried out a study on a mouse 
model, reported that clomiphene citrate 
treatment during pregnancy was associated with 
decreased fetal growth, decreased implantation 
rates, and increased rates of fetal growth 
retardation among offspring of mice treated with 
clomiphene citrate just before ovulation in doses 
similar to those used in humans. In that study, it 
was concluded that preovulatory administration 
of clomiphene impairs uterine function, which 
subsequently reduces embryonic growth and 
development. These findings were corroborated 
by some other studies that reported low birth 
weight of babies born to women who conceived 
following treatment with clomiphene citrate 
(Sharma et al., 2014, Forman et al., 2007).  
An observation of the highest and lowest means 
coupled with the standard deviation values of the 
different heart weights showed that there was a 
significant difference between the control and 
clomiphene citrate groups and between the 
control and letrozole groups with a p-value 
<0.05. However, there was no significant 
difference between the clomiphene citrate and 
letrozole groups. This implies that, these drugs 
have likely initiated some muscle cell 
degeneration resulting in loss of weight of the 
organs, compared to the control group which 
possessed the highest weight. Apparently, 
clomiphene citrate and letrozole function in a 
similar fashion; however, there is no evidence to 
suggest that clomiphene citrate has more 
deleterious effects since there was no significant 
difference between the two groups. 
Furthermore, the highest and lowest means with 
standard deviation values of the average number 
of litters born across the three groups showed 
no statistical significance. Hence, there was no 
significant difference between the control and 
experimental groups in regard to this outcome. 
Myocardial infarction (MI) in neonates is rare but 
has been described in cases of congenital heart 
disease, abnormal coronary arteries (anomalous 
origin and course of coronary arteries), 
thromboembolic events, and perinatal asphyxia 
(Leanne de Vetten et al., 2011). One of the most 
common and clinically significant forms of acute 
cardiac injury is MI, and it results in ischemic 
death of cardiomyocytes (Ibanez et al., 2015).  
MI triggers a complex inflammatory reaction 
accompanied by cytokine release and 
inflammatory leukocyte infiltration into the 
endangered myocardial region (Yellon and 
Hausenloy, 2007; Swirski and Nahrendorf, 2013; 
Eltzschig and Eckle, 2011). The inflammatory 
response and the expression of cytokines 
following MI are integral to the healing process 
and may be protective in the early stage of the 
MI through stimulation of myocyte autophagy 
and left ventricular remodelling; however, 
excessive inflammatory responses after MI are 
detrimental for cell survival and extracellular 
matrix integrity (Nahrendorf et al., 2010; Nian et 
al., 2004; Frangogiannis et al., 2008). This may 
consequently impair left ventricular contractile 
function. 
The degree of infarction that was observed 
amongst the experimental groups in this study, 
is indicative of some necrotic processes taking 
place in the cardiac tissue. Necrosis of 
cardiomyocytes presents with a mixed 
inflammatory response that becomes more 
mononuclear in character with macrophages 
phagocytizing cell debris (Clements et al. 2010). 
The presence of inflammation in these tissues 
was established by the accumulation of 
inflammatory cells in the myocardium of the left 




ventricle. This observation was predominant in 
the cardiac tissues of pups belonging to the 
group that received clomiphene citrate and, to a 
lesser degree, in the cardiac tissues of pups in 
the letrozole group. The presence of 
inflammatory cells suggests a cardiac injury 
sequel to MI in the cardiac tissue. This group also 
presented with the lowest heart weights which is 
suggestive of muscle cells degeneration. The 
observed lack of a significant difference in the 
mean thickness of the wall of the left ventricles 
of the pups between the two experimental 
groups suggests that none of the drugs is 
superior to the other in terms of safety and 
damage to the ventricular wall. 
In conclusion, Clomiphene citrate and letrozole 
have been considered to be safe for ovulation 
induction until recently. However, this study has 
been able to show the deleterious effects that 
these drugs could have on pups of Wistar rats. 
It remains to be seen whether this finding will be 
observed in same manner in similar study in 
humans. 
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